Ecobiotics
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Queensland, 4884, AustraliaPhone Number
+61 740897777Website
www.ecobiotics.com.auRevenue
<$5 MillionIndustry
ZI Rank: 1
About Ecobiotics
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ecobiotics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Ecobiotics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ecobiotics
Check if Ecobiotics has recently received funding, and reach out quickly before it becomes old news!
Check out if Ecobiotics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Ecobiotics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ecobiotics has new funding data
Ecobiotics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Ecobiotics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Ecobiotics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Ecobiotics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ecobiotics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ecobiotics.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Ecobiotics
QBiotics specializes in the discovery and development of novel cell signaling small molecules aimed at improving lives through innovative medical solutions. Their portfolio includes anticancer pharmaceuticals, such as tigilanol tiglate, currently in Phase II clinical trials for soft tissue sarcomas and head and neck cancers, and EBC-1013, a wound h... Read More
